UVA ENCOMPASS HEALTH REHABILITATION — History
CCN 493029 | 3-year financial timeline | COVID resilience: 47/100
🛡️ Public data only — no PHI permitted on this instance.
$24M
Latest Revenue (FY2022)
+1.5%
Revenue CAGR (3yr)
10.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $23M | $23M | $24M | +3.7% | +1.5% |
| Operating Expenses | $20M | $20M | $22M | +6.4% | +3.0% |
| Operating Margin | 13.2% | 12.9% | 10.6% | -17.8% | -10.4% |
| Net Income | $3M | $3M | $3M | -14.8% | -9.1% |
| Licensed Beds | 50 | 50 | 50 | +0.0% | +0.0% |
| Total Patient Days | 16,024 | 15,408 | 15,112 | -1.9% | -2.9% |
| Medicare Day % | 62% | 56% | 56% | -1.2% | -5.4% |
| Medicaid Day % | 1% | 1% | 0% | -88.4% | -58.5% |
COVID Impact & Recovery
Resilience Score: 47/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +2.9% ($23M → $24M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+1.5%
This Hospital
+7.6%
State Avg
Latest Margin
10.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $24M | 9.3% |
| FY2024 (proj) | $25M | 8.0% |
| FY2025 (proj) | $25M | 6.7% |